Restless Legs Syndrome  >>  ropinirole IR  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
ropinirole IR / Generic mfg.
NCT00996944: Clinical Evaluation of Ropinirole IR (Immediate Release) Tablets in Patients Who Are Diagnosed With Symptomatic Restless Legs Syndrome (RLS) Associated With Chronic Kidney Disease (CKD) Managed With Haemodialysis (Including Haemofiltration and Haemodiafiltration)

Terminated
2
34
Japan
Ropinirole immediate release (IR), Placebo
GlaxoSmithKline
Restless Legs Syndrome
06/10
06/10

Download Options